Brian Windsor

Brian Windsor

Company: Lung Therapeutics

Job title: Chief Executive Officer

Seminars:

Divulging the Clinical Development of LTI-03 in IPF 9:40 am

Assessing the “dual threat” of LTI-03: inhibition of the profibrotic process and lung regenerative effects Uncovering how biomarkers could be used to reveal these propertiesRead more

day: Day Two

Panel Discussion: Reflecting on the Progress & Lessons Learned in IPF Clinical Drug Development – Where Will the IPF Road Lead us Next? 11:00 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.